menu
    • menu

    Company profile for BioTheryX

    NEW Drugs in Dev: 3
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BioTheryX, Inc., founded by the drug development team behind the remarkable IMiDs® franchise of compounds, is applying its extensive and proven commercial success to deliver efficacious therapies to patients with unmet medical needs. The identification of Cereblon (an E3 ligase) as a key target of the IMiDs® (the most successful class of anti-cancer drug in the world) showed that targeting protein degradation is a viable dru...
    BioTheryX, Inc., founded by the drug development team behind the remarkable IMiDs® franchise of compounds, is applying its extensive and proven commercial success to deliver efficacious therapies to patients with unmet medical needs. The identification of Cereblon (an E3 ligase) as a key target of the IMiDs® (the most successful class of anti-cancer drug in the world) showed that targeting protein degradation is a viable drug development strategy that can lead to enormous commercial success. With unmatched commercial and scientific experience, the BioTheryX drug development team is building a set of high value assets in protein modulation

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BioTheryXUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    20 Cabin Ridge Road Chappaqua, NY 10514
    Telephone
    Telephone
    (914) 490-5425
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://biotheryx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biotheryx to Share Phase 1A BTX-9341 Breast Cancer Data at ESMO
    Biotheryx to Share Phase 1A BTX-9341 Breast Cancer Data at ESMO

    04 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biotheryx-to-present-results-from-its-phase-1a-dose-escalation-study-of-btx-9341-for-the-treatment-of-hrher2--breast-cancer-at-the-2026-european-society-for-medical-oncology-breast-cancer-annual-congress-302760537.html

    PR NEWSWIRE
    04 May 2026
    Share Share
    Biotheryx Completes Phase 1A Trial Enrollment For BTX-9341
    Biotheryx Completes Phase 1A Trial Enrollment For BTX-9341

    17 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biotheryx-announces-completion-of-enrollment-in-phase-1a-clinical-trial-of-btx-9341-for-the-treatment-hrher2--breast-cancer-302616179.html

    PR NEWSWIRE
    17 Nov 2025
    Share Share
    Texas A&M Health and BurstIQ Partner to Revolutionize Clinical Genomics Research
    Texas A&M Health and BurstIQ Partner to Revolutionize Clinical Genomics Research

    17 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/texas-am-health-and-burstiq-partner-to-revolutionize-clinical-genomics-research-302199330.html

    PR NEWSWIRE
    17 Jul 2024
    Share Share
    Biotheryx Announces FDA Clearance of NDA for BTX-9341 Dual Bifunctional Degrader
    Biotheryx Announces FDA Clearance of NDA for BTX-9341 Dual Bifunctional Degrader

    07 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biotheryx-announces-us-fda-clearance-of-investigational-new-drug-application-for-btx-9341-a-first-in-class-dual-bifunctional-degrader-of-cdk46-302137704.html

    PR NEWSWIRE
    07 May 2024
    Share Share
    Biotheryx to Present New Preclinical Data on Bifunctional Degraders
    Biotheryx to Present New Preclinical Data on Bifunctional Degraders

    25 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biotheryx-to-present-new-preclinical-data-on-bifunctional-degraders-for-cdk46-and-sos1-at-2023-asco-annual-meeting-301835151.html

    PR NEWSWIRE
    25 May 2023
    Share Share
    Biotheryx Presents Preclinical CDK4/6 & SOS1 Protein Degrader Data at AACR 2023
    Biotheryx Presents Preclinical CDK4/6 & SOS1 Protein Degrader Data at AACR 2023

    17 Apr 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/biotheryx-presents-preclinical-cdk46-and-sos1-protein-degrader-data-at-aacr-2023-annual-meeting-301798000.html

    PR NEWSWIRE
    17 Apr 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search